Review decisions

Showing 180 results of 291 total
Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00151
Issued / Original Publication Date: 2017-01-23
Summary Safety Review - Oral Retinoid Products - Assessing the Potential Risk of Impotence (erectile dysfunction)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00143
Issued / Original Publication Date: 2017-01-10
Summary Safety Review - KEPPRA (levetiracetam) - Assessing the Potential Risk of Acute Kidney Injury (Acute renal failure/Interstitial nephritis)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00142
Issued / Original Publication Date: 2017-01-06
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00144
Issued / Original Publication Date: 2017-01-06
Summary Safety Review - Amiodarone (intravenous) - Assessing the potential risk of side effects in fetuses and newborns
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00145
Issued / Original Publication Date: 2017-01-06
Summary Safety Review - Direct-acting antivirals - Assessing the Potential Risk of Hepatitis B Virus Reactivation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00138
Issued / Original Publication Date: 2016-12-01
Summary Safety Review - Bisphosphonates - Assessing the Risk of Jaw Bone Loss (osteonecrosis of the jaw)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00137
Issued / Original Publication Date: 2016-11-25
Summary Safety Review - Phenylephrine and acetaminophen - Drug-drug interaction
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00136
Issued / Original Publication Date: 2016-11-23
Summary Safety Review - ZOFRAN (ondansetron) - Assessing the Potential Harm to the Fetus
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00135
Issued / Original Publication Date: 2016-11-16
Summary Safety Review - DPP-4 inhibitors (gliptins) - Assessing the Potential Risk of Gastrointestinal Blockage (Gastrointestinal Obstruction)
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00123
Issued / Original Publication Date: 2016-11-14

Displaying 171 - 180 of 291 | Page 18 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: